Lewy body dementia and Parkinson’s disease with dementia

[1]  P. Lewczuk,et al.  Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases. , 2008, Methods.

[2]  Pasquale Calabrese,et al.  Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument , 2008 .

[3]  Matthias Reimold,et al.  [11C]PIB binding in Parkinson's disease dementia , 2008, NeuroImage.

[4]  Jonathon O’Brien,et al.  Differentiating the dementias. Revisiting synucleinopathies and tauopathies. , 2008, Current Alzheimer research.

[5]  P. Riederer,et al.  Cognitive impairment in 873 patients with idiopathic Parkinson's disease , 2008, Journal of Neurology.

[6]  A. Siderowf,et al.  Cognitive Impairment in Parkinson’s Disease and Dementia with Lewy Bodies: A Spectrum of Disease , 2007, Neurosignals.

[7]  I. McKeith.  Dementia with Lewy bodies and Parkinson’s disease with dementia: where two worlds collide , 2007, Practical Neurology.

[8]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[9]  R. Dodel,et al.  [Depression in Parkinson's disease. Assessment and treatment]. , 2007, Der Nervenarzt.

[10]  R. Dodel,et al.  Depression bei M. Parkinson , 2007, Der Nervenarzt.

[11]  E. Londos,et al.  Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease. , 2007, Alzheimer disease and associated disorders.

[12]  D J Brooks,et al.  DLB and PDD boundary issues , 2007, Neurology.

[13]  W. Poewe.  Dysautonomia and cognitive dysfunction in Parkinson's disease , 2007, Movement Disorders.

[14]  E. Tolosa,et al.  Cognitive dysfunction and dementia in Parkinson disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[15]  T. Tokuda,et al.  Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease. , 2006 .

[16]  Julien Doyon,et al.  Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases , 2006, The Lancet Neurology.

[17]  K. Jellinger.  Neuropathology of dementia in Parkinson's disease , 2006, Annals of neurology.

[18]  M. Boustani,et al.  Cholinesterase inhibitors for Parkinson's disease dementia. , 2006, The Cochrane database of systematic reviews.

[19]  J. Wiltfang,et al.  Total tau protein, phosphorylated tau (181p) protein, β-amyloid1–42, and β-amyloid1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies , 2006 .

[20]  T. Tokuda,et al.  Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease. , 2006, Biochemical and biophysical research communications.

[21]  J. Wiltfang,et al.  Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies. , 2006, Clinical chemistry and laboratory medicine.

[22]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[23]  C. Brayne,et al.  A systematic review of prevalence and incidence studies of dementia with Lewy bodies. , 2005, Age and ageing.

[24]  D. Aarsland,et al.  A systematic review of prevalence studies of dementia in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[25]  I. Katz,et al.  Antidepressant studies in Parkinson's disease: A review and meta‐analysis , 2005, Movement disorders : official journal of the Movement Disorder Society.

[26]  U P Mosimann,et al.  Visual perception in Parkinson disease dementia and dementia with Lewy bodies , 2004, Neurology.

[27]  Günther Deuschl,et al.  Rivastigmine for dementia associated with Parkinson's disease. , 2004, The New England journal of medicine.

[28]  R. Marconi,et al.  Quetiapine and Clozapine in Parkinsonian Patients With Dopaminergic Psychosis , 2004, Clinical neuropharmacology.

[29]  C. Clarke,et al.  Therapies for depression in Parkinson's disease , 2003 .

[30]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[31]  Clarke Ce,et al.  Therapies for depression in Parkinson's disease. , 2003, The Cochrane database of systematic reviews.

[32]  Z Walker,et al.  Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand , 2002, Journal of neurology, neurosurgery, and psychiatry.

[33]  J D Fenwick,et al.  Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD , 2001, Neurology.

[34]  Murat Emre,et al.  Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study , 2000, The Lancet.

[35]  H. Arai,et al.  18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies , 2000, Neurology.

[36]  D. Aarsland,et al.  Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study , 2000, Journal of the American Geriatrics Society.

[37]  S. Wisniewski,et al.  Predictors of progression in patients with AD and Lewy bodies , 2000, Neurology.

[38]  Martí-Massó Jf,et al.  [Dementia with Lewy bodies]. , 2000, Neurologia.

[39]  V. Lee,et al.  Dementia with Lewy bodies , 1999, Neurology.

[40]  I G McKeith,et al.  EEG findings in dementia with Lewy bodies and Alzheimer’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[41]  L. Thal,et al.  Cognitive decline is faster in Lewy body variant than in Alzheimer's disease , 1998, Neurology.

[42]  V Hachinski,et al.  Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease , 1996, Neurology.

[43]  G. Stebbins,et al.  Risk factors for nursing home placement in advanced Parkinson's disease , 1993, Neurology.

[44]  E. Perry,et al.  Neuroleptic sensitivity in patients with senile dementia of Lewy body type. , 1992, BMJ.

[45]  R G Robinson,et al.  Depression in Parkinson's Disease , 1990, The Journal of nervous and mental disease.

[46]  R. Blunden.  Assessment and Treatment , 1982 .